PA SB1091 | 2021-2022 | Regular Session

Status

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 23 2022 - 25% progression, died in committee
Action: 2022-02-23 - Referred to HEALTH AND HUMAN SERVICES
Pending: Senate Health & Human Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Sponsors


History

DateChamberAction
2022-02-23SenateReferred to HEALTH AND HUMAN SERVICES

Pennsylvania State Sources


Bill Comments

feedback